• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奈奥辛和盘基兰尼酯用于盐酸纳曲酮眼部给药:形态学、流变学、铺展性能和光保护作用。

Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.

机构信息

School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.

出版信息

Int J Pharm. 2012 Aug 20;433(1-2):142-8. doi: 10.1016/j.ijpharm.2012.05.011. Epub 2012 May 14.

DOI:10.1016/j.ijpharm.2012.05.011
PMID:22595640
Abstract

Naltrexone hydrochloride (NTX) is a promising treatment for corneal disorders linked to diabetes mellitus (diabetic keratopathy). However, NTX has a major stability problem due to autoxidation, which is likely to hinder its formulation as eye drops for treatment of diabetic keratopathy. In this study, in-house developed NTX non-ionic surfactant vesicles (niosomes and discomes) were evaluated for their spreading, rheological properties and their ability to impede the inevitable autoxidation of NTX in aqueous solutions. The measured contact angles and spreading coefficients for niosomes reflected significantly (P<0.05) better wetting and spreading abilities than the aqueous vehicle. The prepared niosomes were significantly more viscous (P<0.05) than the aqueous solution. The lipid content, size and composition of niosomes are the main factors affecting the viscosity of niosomal dispersions. Exposure of NTX solution to artificial daylight illumination (10,000 lux) can produce extensive degradation of NTX due to oxidation. The prepared formulations were able to significantly (P<0.05) protect the encapsulated NTX from the photo-induced oxidation compared with free NTX solutions. The investigated niosomes lend themselves as a potential ocular delivery modality for NTX.

摘要

盐酸纳曲酮(NTX)是一种有前途的治疗与糖尿病相关的角膜疾病(糖尿病性角膜病变)的方法。然而,由于自氧化,NTX 存在严重的稳定性问题,这可能会阻碍其作为治疗糖尿病性角膜病变的滴眼剂的配方。在这项研究中,我们评估了内部开发的 NTX 非离子表面活性剂囊泡(niosomes 和 discomes)在水基溶液中的铺展、流变性能以及抑制 NTX 不可避免的自氧化的能力。niosomes 的测量接触角和铺展系数明显(P<0.05)反映出比水性载体更好的润湿性和铺展能力。制备的 niosomes 的粘度明显(P<0.05)高于水溶液。niosomes 的脂质含量、大小和组成是影响其分散体粘度的主要因素。将 NTX 溶液暴露于人工日光照射(10,000 lux)下会因氧化而导致 NTX 广泛降解。与游离 NTX 溶液相比,所制备的制剂能够显著(P<0.05)保护包封的 NTX 免受光诱导氧化。所研究的 niosomes 可作为 NTX 的潜在眼部递药方式。

相似文献

1
Niosomes and discomes for ocular delivery of naltrexone hydrochloride: morphological, rheological, spreading properties and photo-protective effects.奈奥辛和盘基兰尼酯用于盐酸纳曲酮眼部给药:形态学、流变学、铺展性能和光保护作用。
Int J Pharm. 2012 Aug 20;433(1-2):142-8. doi: 10.1016/j.ijpharm.2012.05.011. Epub 2012 May 14.
2
Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.制备作为盐酸纳曲酮眼部给药系统的囊泡:物理化学表征
Pharmazie. 2010 Nov;65(11):811-7.
3
Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery.盐酸纳曲酮眼用控释囊泡和盘状给药系统的设计与评价。
J Pharm Sci. 2011 May;100(5):1833-46. doi: 10.1002/jps.22422. Epub 2011 Jan 18.
4
Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models.眼部纳曲酮脂质体及其成分在鸡胚绒毛尿囊膜和离体牛角膜模型上的结膜和角膜耐受性评估
Int J Pharm. 2012 Aug 1;432(1-2):1-10. doi: 10.1016/j.ijpharm.2012.04.063. Epub 2012 Apr 30.
5
Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation.盐酸纳曲酮多泡脂质体的缓释:设计、表征和体外/体内评价。
Pharm Dev Technol. 2013 Jul-Aug;18(4):828-33. doi: 10.3109/10837450.2012.700934. Epub 2012 Jul 3.
6
Novel in situ gelling ocular films for the opioid growth factor-receptor antagonist-naltrexone hydrochloride: fabrication, mechanical properties, mucoadhesion, tolerability and stability studies.用于阿片样生长因子受体拮抗剂盐酸纳曲酮的新型原位凝胶眼用薄膜:制备、力学性能、粘膜粘附性、耐受性及稳定性研究
Int J Pharm. 2014 Dec 30;477(1-2):631-42. doi: 10.1016/j.ijpharm.2014.10.069. Epub 2014 Nov 4.
7
Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.与 2 型糖尿病相关的眼表面异常可被阿片受体拮抗剂纳曲酮逆转。
Clin Exp Ophthalmol. 2014 Mar;42(2):159-68. doi: 10.1111/ceo.12144. Epub 2013 Jul 29.
8
Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats.阿片受体拮抗剂纳曲酮局部治疗促进糖尿病大鼠全层伤口愈合。
Exp Biol Med (Maywood). 2011 Oct;236(10):1122-32. doi: 10.1258/ebm.2011.011163. Epub 2011 Sep 14.
9
Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats.纳曲酮和胰岛素在加速 I 型糖尿病大鼠角膜上皮愈合方面均独立有效,但无相加作用。
Exp Eye Res. 2009 Nov;89(5):686-92. doi: 10.1016/j.exer.2009.06.010. Epub 2009 Jul 1.
10
Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone.稳态眼表上皮对阿片类拮抗剂纳曲酮慢性治疗的适应性
Cornea. 2006 Aug;25(7):821-9. doi: 10.1097/01.ico.0000224646.66472.aa.

引用本文的文献

1
A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems.基于多糖的囊泡作为药物递送系统的近期生物医学应用的最新技术综述
Polymers (Basel). 2025 Jun 4;17(11):1566. doi: 10.3390/polym17111566.
2
A Comprehensive Review on Recent Advances and Patents of Niosomes.关于非离子表面活性剂囊泡的最新进展与专利的综合综述
Recent Pat Nanotechnol. 2025;19(3):364-380. doi: 10.2174/0118722105259776231002071218.
3
Niosome-loaded Tet-Amp against S. aureus, K. pneumoniae, and P. aeruginosa.负载奈米囊泡的四环素-氨苄西林对金黄色葡萄球菌、肺炎克雷伯菌和铜绿假单胞菌的作用。
Braz J Microbiol. 2024 Dec;55(4):3563-3589. doi: 10.1007/s42770-024-01516-6. Epub 2024 Oct 23.
4
How the designed processing parameters affect the liquid mixture density and viscosity of the tretinoin-loaded niosomes at different temperatures?在不同温度下,设计的工艺参数如何影响载有维甲酸的非离子表面活性剂囊泡的液体混合物密度和粘度?
Heliyon. 2024 Sep 14;10(18):e37925. doi: 10.1016/j.heliyon.2024.e37925. eCollection 2024 Sep 30.
5
Nanovesicles as Potential Carriers for Delivery of Antiviral Drugs: A Comprehensive Review.纳米囊泡作为抗病毒药物递送的潜在载体:综述
Curr Drug Deliv. 2025;22(6):746-760. doi: 10.2174/0115672018313783240603114509.
6
Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery.囊泡药物递送系统:眼部药物递送的有前景的方法。
Pharmaceuticals (Basel). 2024 Apr 16;17(4):511. doi: 10.3390/ph17040511.
7
Designed Fabrication of Phloretin-Loaded Propylene Glycol Binary Ethosomes: Stability, Skin Permeability and Antioxidant Activity.丁香素负载丙二醇二元醇醚的设计制备:稳定性、经皮渗透性和抗氧化活性。
Molecules. 2023 Dec 21;29(1):66. doi: 10.3390/molecules29010066.
8
Current advances in niosomes applications for drug delivery and cancer treatment.非离子表面活性剂囊泡在药物递送和癌症治疗中的应用现状进展
Mater Today Bio. 2023 Oct 21;23:100837. doi: 10.1016/j.mtbio.2023.100837. eCollection 2023 Dec.
9
A Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery.载药囊泡作为高级药物传递工具的全面综述。
Pharm Nanotechnol. 2024;12(3):206-228. doi: 10.2174/2211738511666230726154557.
10
Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells.设计并优化负载植物化学药物的聚乙二醇化非离子表面活性剂囊泡纳米颗粒的各种制剂:对人肺癌细胞的潜在抗癌作用
Pharmacol Rep. 2023 Apr;75(2):442-455. doi: 10.1007/s43440-023-00462-8. Epub 2023 Mar 1.